论文部分内容阅读
目的评价研究新生儿ABO溶血病应用丙种球蛋白治疗的效果。方法随机的将2010年1月~2013年1月本科收治的新生儿ABO溶血病患者76例分成对照组和观察组各38例、对照组患者常规应用蓝光照射治疗、观察组患者在蓝光照射的同时应用丙种球蛋白注射治疗,比较两组患者胆红素日均下降水平以及治疗3天后总胆红素水平。结果观察组患者胆红素日均下降水平低于对照组患者,两组比较差异具有显著统计学意义(P<0.01);治疗3天后观察组患者总胆红素水平低于对照组患者,两组比较差异具有统计学意义(P<0.05)。结论应用丙种球蛋白治疗新生儿ABO溶血病能够快速有效的降低胆红素水平、促进患者快速的恢复,临床应用前景广泛。
Objective To evaluate the effect of gamma globulin treatment on neonatal ABO hemolytic disease. Methods Randomly divided 76 neonates with ABO hemolytic disease from January 2010 to January 2013 into 38 cases in the control group and the observation group. The patients in the control group were treated routinely with blue light irradiation. The patients in the observation group under blue light irradiation At the same time the application of gamma globulin injection therapy, compared with the average daily decline in patients with bilirubin and the total bilirubin levels after 3 days of treatment. Results The average daily decline of bilirubin in the observation group was lower than that in the control group, with significant difference between the two groups (P <0.01). After 3 days of treatment, the total bilirubin level in the observation group was lower than that in the control group The difference was statistically significant (P <0.05). Conclusion The application of gamma globulin in neonatal ABO hemolytic disease can quickly and effectively reduce the level of bilirubin and promote the rapid recovery of patients with a wide range of clinical applications.